Addressing sleep-related complaints may enhance symptomatic treatment and management of PAH. Most patients with pulmonary arterial hypertension (PAH) suffered from poor sleep quality, and dyspnea was ...

The following is a summary of “Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial,” ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has ...

Adding Uptravi (selexipag) to standard-of-care PAH treatment within six months may reduce the risk of hospitalization, per a ...

A new study published in the journal of Arthritis & Rheumatology showed that interstitial lung disease (ILD) can occur in ...

In patients with PAH, reducing peripheral serotonin using rodatristat ethyl negatively affects pulmonary hemodynamics and cardiac function.

Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...

With a focus on innovation, patient-centered care, and collaboration, Pulnovo Medical, a rising star in the realm of ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Gossamer Bio (GOSS – Research Report). The associated ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and ...

A feeling of heaviness in chest may not always be related to a heart attack. Here are 9 other causes that can lead to a tight ...

Although several Group 1 PH (Pulmonary Arterial Hypertension, PAH) medications have been explored in Group 2 PH, to date, no medications have been approved for its treatment. Tectonic is a ...